You are here

Commentary

Health Care Blog Watch

Pay-for-Delay and Authorized Generics Back in the Spotlight
Miriam Reisman
PDF version: 
Blogs in health care and law are abuzz over a bill to restrict drug companies from “pay-for-delay” patent settlements that postpone the introduction of generics.